Copyright Reports & Markets. All rights reserved.

Global and United States Palonosetron Hydrochloride Injection Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Palonosetron Hydrochloride Injection Product Introduction
    • 1.2 Global Palonosetron Hydrochloride Injection Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Palonosetron Hydrochloride Injection Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Palonosetron Hydrochloride Injection Sales in Volume for the Year 2017-2028
    • 1.3 United States Palonosetron Hydrochloride Injection Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Palonosetron Hydrochloride Injection Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Palonosetron Hydrochloride Injection Sales in Volume for the Year 2017-2028
    • 1.4 Palonosetron Hydrochloride Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Palonosetron Hydrochloride Injection in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Palonosetron Hydrochloride Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Palonosetron Hydrochloride Injection Market Dynamics
      • 1.5.1 Palonosetron Hydrochloride Injection Industry Trends
      • 1.5.2 Palonosetron Hydrochloride Injection Market Drivers
      • 1.5.3 Palonosetron Hydrochloride Injection Market Challenges
      • 1.5.4 Palonosetron Hydrochloride Injection Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Palonosetron Hydrochloride Injection Market Segment by Type
      • 2.1.1 1.5ml
      • 2.1.2 5ml
    • 2.2 Global Palonosetron Hydrochloride Injection Market Size by Type
      • 2.2.1 Global Palonosetron Hydrochloride Injection Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Palonosetron Hydrochloride Injection Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Palonosetron Hydrochloride Injection Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Palonosetron Hydrochloride Injection Market Size by Type
      • 2.3.1 United States Palonosetron Hydrochloride Injection Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Palonosetron Hydrochloride Injection Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Palonosetron Hydrochloride Injection Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Palonosetron Hydrochloride Injection Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Pharmacy
      • 3.1.3 Other
    • 3.2 Global Palonosetron Hydrochloride Injection Market Size by Application
      • 3.2.1 Global Palonosetron Hydrochloride Injection Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Palonosetron Hydrochloride Injection Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Palonosetron Hydrochloride Injection Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Palonosetron Hydrochloride Injection Market Size by Application
      • 3.3.1 United States Palonosetron Hydrochloride Injection Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Palonosetron Hydrochloride Injection Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Palonosetron Hydrochloride Injection Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Palonosetron Hydrochloride Injection Competitor Landscape by Company

    • 4.1 Global Palonosetron Hydrochloride Injection Market Size by Company
      • 4.1.1 Top Global Palonosetron Hydrochloride Injection Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Palonosetron Hydrochloride Injection Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Palonosetron Hydrochloride Injection Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Palonosetron Hydrochloride Injection Price by Manufacturer (2017-2022)
    • 4.2 Global Palonosetron Hydrochloride Injection Concentration Ratio (CR)
      • 4.2.1 Palonosetron Hydrochloride Injection Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Palonosetron Hydrochloride Injection in 2021
      • 4.2.3 Global Palonosetron Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Palonosetron Hydrochloride Injection Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Palonosetron Hydrochloride Injection Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Palonosetron Hydrochloride Injection Product Type
      • 4.3.3 Date of International Manufacturers Enter into Palonosetron Hydrochloride Injection Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Palonosetron Hydrochloride Injection Market Size by Company
      • 4.5.1 Top Palonosetron Hydrochloride Injection Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Palonosetron Hydrochloride Injection Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Palonosetron Hydrochloride Injection Sales by Players (2020, 2021 & 2022)

    5 Global Palonosetron Hydrochloride Injection Market Size by Region

    • 5.1 Global Palonosetron Hydrochloride Injection Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Palonosetron Hydrochloride Injection Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Palonosetron Hydrochloride Injection Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Palonosetron Hydrochloride Injection Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Palonosetron Hydrochloride Injection Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Palonosetron Hydrochloride Injection Sales in Value by Region: 2017-2022
      • 5.3.2 Global Palonosetron Hydrochloride Injection Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Palonosetron Hydrochloride Injection Market Size YoY Growth 2017-2028
      • 6.1.2 North America Palonosetron Hydrochloride Injection Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Palonosetron Hydrochloride Injection Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Palonosetron Hydrochloride Injection Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Palonosetron Hydrochloride Injection Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Palonosetron Hydrochloride Injection Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Palonosetron Hydrochloride Injection Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Palonosetron Hydrochloride Injection Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Palonosetron Hydrochloride Injection Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Palonosetron Hydrochloride Injection Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Helsinn Healthcare
      • 7.1.1 Helsinn Healthcare Corporation Information
      • 7.1.2 Helsinn Healthcare Description and Business Overview
      • 7.1.3 Helsinn Healthcare Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Helsinn Healthcare Palonosetron Hydrochloride Injection Products Offered
      • 7.1.5 Helsinn Healthcare Recent Development
    • 7.2 AuroMedics Pharma
      • 7.2.1 AuroMedics Pharma Corporation Information
      • 7.2.2 AuroMedics Pharma Description and Business Overview
      • 7.2.3 AuroMedics Pharma Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 AuroMedics Pharma Palonosetron Hydrochloride Injection Products Offered
      • 7.2.5 AuroMedics Pharma Recent Development
    • 7.3 Apotex
      • 7.3.1 Apotex Corporation Information
      • 7.3.2 Apotex Description and Business Overview
      • 7.3.3 Apotex Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Apotex Palonosetron Hydrochloride Injection Products Offered
      • 7.3.5 Apotex Recent Development
    • 7.4 Teva Pharmaceuticals
      • 7.4.1 Teva Pharmaceuticals Corporation Information
      • 7.4.2 Teva Pharmaceuticals Description and Business Overview
      • 7.4.3 Teva Pharmaceuticals Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Teva Pharmaceuticals Palonosetron Hydrochloride Injection Products Offered
      • 7.4.5 Teva Pharmaceuticals Recent Development
    • 7.5 Hikma Pharmaceuticals
      • 7.5.1 Hikma Pharmaceuticals Corporation Information
      • 7.5.2 Hikma Pharmaceuticals Description and Business Overview
      • 7.5.3 Hikma Pharmaceuticals Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Hikma Pharmaceuticals Palonosetron Hydrochloride Injection Products Offered
      • 7.5.5 Hikma Pharmaceuticals Recent Development
    • 7.6 Pfizer
      • 7.6.1 Pfizer Corporation Information
      • 7.6.2 Pfizer Description and Business Overview
      • 7.6.3 Pfizer Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Pfizer Palonosetron Hydrochloride Injection Products Offered
      • 7.6.5 Pfizer Recent Development
    • 7.7 Chia Tai Tianqing Pharmaceutical Group
      • 7.7.1 Chia Tai Tianqing Pharmaceutical Group Corporation Information
      • 7.7.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
      • 7.7.3 Chia Tai Tianqing Pharmaceutical Group Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Chia Tai Tianqing Pharmaceutical Group Palonosetron Hydrochloride Injection Products Offered
      • 7.7.5 Chia Tai Tianqing Pharmaceutical Group Recent Development
    • 7.8 Aosaikang Pharmaceutical
      • 7.8.1 Aosaikang Pharmaceutical Corporation Information
      • 7.8.2 Aosaikang Pharmaceutical Description and Business Overview
      • 7.8.3 Aosaikang Pharmaceutical Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Aosaikang Pharmaceutical Palonosetron Hydrochloride Injection Products Offered
      • 7.8.5 Aosaikang Pharmaceutical Recent Development
    • 7.9 Kunming Jida Pharmaceutical
      • 7.9.1 Kunming Jida Pharmaceutical Corporation Information
      • 7.9.2 Kunming Jida Pharmaceutical Description and Business Overview
      • 7.9.3 Kunming Jida Pharmaceutical Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Kunming Jida Pharmaceutical Palonosetron Hydrochloride Injection Products Offered
      • 7.9.5 Kunming Jida Pharmaceutical Recent Development
    • 7.10 Haisco Pharmaceutical Group
      • 7.10.1 Haisco Pharmaceutical Group Corporation Information
      • 7.10.2 Haisco Pharmaceutical Group Description and Business Overview
      • 7.10.3 Haisco Pharmaceutical Group Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Haisco Pharmaceutical Group Palonosetron Hydrochloride Injection Products Offered
      • 7.10.5 Haisco Pharmaceutical Group Recent Development
    • 7.11 Chongqing Huapont Pharmaceutical
      • 7.11.1 Chongqing Huapont Pharmaceutical Corporation Information
      • 7.11.2 Chongqing Huapont Pharmaceutical Description and Business Overview
      • 7.11.3 Chongqing Huapont Pharmaceutical Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Chongqing Huapont Pharmaceutical Palonosetron Hydrochloride Injection Products Offered
      • 7.11.5 Chongqing Huapont Pharmaceutical Recent Development
    • 7.12 Qilu Pharmaceutical
      • 7.12.1 Qilu Pharmaceutical Corporation Information
      • 7.12.2 Qilu Pharmaceutical Description and Business Overview
      • 7.12.3 Qilu Pharmaceutical Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Qilu Pharmaceutical Products Offered
      • 7.12.5 Qilu Pharmaceutical Recent Development
    • 7.13 Sichuan Hairong Pharmaceutical
      • 7.13.1 Sichuan Hairong Pharmaceutical Corporation Information
      • 7.13.2 Sichuan Hairong Pharmaceutical Description and Business Overview
      • 7.13.3 Sichuan Hairong Pharmaceutical Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 Sichuan Hairong Pharmaceutical Products Offered
      • 7.13.5 Sichuan Hairong Pharmaceutical Recent Development
    • 7.14 Pku Healthcare
      • 7.14.1 Pku Healthcare Corporation Information
      • 7.14.2 Pku Healthcare Description and Business Overview
      • 7.14.3 Pku Healthcare Palonosetron Hydrochloride Injection Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 Pku Healthcare Products Offered
      • 7.14.5 Pku Healthcare Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Palonosetron Hydrochloride Injection Industry Chain Analysis
    • 8.2 Palonosetron Hydrochloride Injection Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Palonosetron Hydrochloride Injection Distributors
    • 8.3 Palonosetron Hydrochloride Injection Production Mode & Process
    • 8.4 Palonosetron Hydrochloride Injection Sales and Marketing
      • 8.4.1 Palonosetron Hydrochloride Injection Sales Channels
      • 8.4.2 Palonosetron Hydrochloride Injection Distributors
    • 8.5 Palonosetron Hydrochloride Injection Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Palonosetron Hydrochloride Injection is a prescription medicine called an "antiemetic." It is used in adults to help prevent the nausea and vomiting that happens.
      Market Analysis and Insights: Global and United States Palonosetron Hydrochloride Injection Market
      This report focuses on global and United States Palonosetron Hydrochloride Injection market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Palonosetron Hydrochloride Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 1.5ml accounting for % of the Palonosetron Hydrochloride Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Palonosetron Hydrochloride Injection market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Palonosetron Hydrochloride Injection Scope and Market Size
      Palonosetron Hydrochloride Injection market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Palonosetron Hydrochloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Palonosetron Hydrochloride Injection market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Palonosetron Hydrochloride Injection market is segmented into
      1.5ml
      5ml
      Segment by Application, the Palonosetron Hydrochloride Injection market is segmented into
      Hospital
      Pharmacy
      Other
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Palonosetron Hydrochloride Injection Market Share Analysis
      Palonosetron Hydrochloride Injection market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Palonosetron Hydrochloride Injection business, the date to enter into the Palonosetron Hydrochloride Injection market, Palonosetron Hydrochloride Injection product introduction, recent developments, etc.
      The major vendors covered:
      Helsinn Healthcare
      AuroMedics Pharma
      Apotex
      Teva Pharmaceuticals
      Hikma Pharmaceuticals
      Pfizer
      Chia Tai Tianqing Pharmaceutical Group
      Aosaikang Pharmaceutical
      Kunming Jida Pharmaceutical
      Haisco Pharmaceutical Group
      Chongqing Huapont Pharmaceutical
      Qilu Pharmaceutical
      Sichuan Hairong Pharmaceutical
      Pku Healthcare
      Buy now